COA5 Gene Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency type 3 NGS Genetic Test
COA5 Gene Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency type 3 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses NGS Technology on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 weeks. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr Pasupathy Arumugam
Consultant Pathologist · Reg: 21521
Last updated: September 7, 2026
Overview
The purpose of this test is to diagnose COA5 gene cardioencephalomyopathy by detecting pathogenic mutations in the COA5 gene using NGS technology, enabling accurate identification and management of this rare genetic disorder.
- Test Code
- 2504
- Price
- ₹20,000
- Sample Type
- Blood or Extracted DNA or One drop Blood on FTA Card
- Result Time
- 3 to 4 weeks
- Fasting Required
- No
- Method
- NGS Technology
COA5 Gene Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency type 3 is a rare genetic disorder that affects the functioning of the cytochrome c oxidase enzyme. This enzyme is responsible for producing energy in our cells. The disorder is characterized by severe muscle weakness, developmental delays, and brain abnormalities. It usually presents in infancy and has a high mortality rate.
A genetic DNA test is available to diagnose COA5 Gene Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency type 3. This test uses Next Generation Sequencing (NGS) technology to analyze a patient's DNA and identify any mutations in the COA5 gene. The test can be performed on blood or saliva samples and costs INR 20000.
Symptoms of COA5 Gene Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency type 3
- Severe muscle weakness
- Developmental delays
- Brain abnormalities
- Respiratory problems
- Feeding difficulties
- Seizures
Diagnosis of COA5 Gene Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency type 3
Diagnosis of COA5 Gene Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency type 3 is typically done through genetic DNA testing. A blood or saliva sample is taken from the patient and analyzed using NGS technology to identify any mutations in the COA5 gene. Other diagnostic tests may be done to rule out other conditions with similar symptoms.
Conclusion
COA5 Gene Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency type 3 is a rare genetic disorder that affects the functioning of the cytochrome c oxidase enzyme. A genetic DNA test using NGS technology is available to diagnose the condition. The test costs INR 20000 and can be performed on blood or saliva samples. If you suspect that you or a loved one may have this condition, it is important to seek medical attention and undergo testing for an accurate diagnosis.
Sample Collection
Patient should provide detailed clinical history and undergo genetic counseling to draw a family pedigree chart for accurate assessment.
Laboratory Analysis
Your sample is analyzed using NGS Technology in our laboratory.
Report Delivery
A certified pathologist reviews and signs your report. You receive it as a secure PDF via email and WhatsApp.
Timeline: 3 to 4 weeks
Patient Instructions
About This Test
Who Should Get This Test
The purpose of this test is to diagnose COA5 gene cardioencephalomyopathy by detecting pathogenic mutations in the COA5 gene using NGS technology, enabling accurate identification and management of this rare genetic disorder.
How to Prepare
- Provide a blood sample, extracted DNA, or one drop of blood on an FTA card as per instructions.
- Ensure proper labeling and handling of samples.
Doctor's Notes
Reviewed by Dr Pasupathy Arumugam — MBBS, MD (Pathology) · Reg. No. 21521
Last updated: September 7, 2026
Test Parameters & Specifications
Understanding Your Results
Positive for pathogenic variant
Indicates diagnosis of COA5 gene cardioencephalomyopathy; clinical correlation and management advised.
Negative for pathogenic variant
No mutations detected; condition unlikely but clinical evaluation may be needed if symptoms persist.
If an infant presents with symptoms such as severe muscle weakness, developmental delays, respiratory issues, or seizures, consult a geneticist or pediatrician promptly.
Risks & Considerations
- ●Minimal risk associated with blood sample collection, such as slight pain or bruising.
- ●Genetic counseling is recommended to understand the psychological and familial implications of results.
Frequently Asked Questions
What is COA5 Gene Cardioencephalomyopathy?
What are the symptoms of this condition?
How is the test performed?
What is the cost of the test?
Is home sample collection available?
How long does it take to get results?
What does a positive result mean?
Can this test be used for prenatal diagnosis?
Is genetic counseling required?
What are the treatment options for this condition?
Is the test covered by insurance?
How accurate is the NGS genetic test?
Related Tests
Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.